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Singing in chronic obstructive
pulmonary disease patients:
A pilot study in Portugal
Cantar em doentes com doenc¸a pulmonar
obstrutiva crônica: um estudo-piloto em
Portugal
Chronic  obstructive  pulmonary  disease  (COPD)  is  a  disor-
der  characterized  by  airﬂow  limitation  that  is  not  fully
reversible.  The  severity  and  magnitude  of  the  symptoms
increase  as  the  disease  progresses,  leading  to  signiﬁcant  dis-
ability  and  a  negative  effect  on  quality  of  life.1--3 Despite
(c)  Singing  training  for  popular  Portuguese  songs,  conducted
by  the  singing  teacher  (35  min).
The  songs  increased  in  difﬁculty  as  the  sessions  pro-
gressed  and  the  patients  were  instructed  to  practice  the
songs  at  home  during  the  week.
The  ﬁnal  evaluation  of  the  patients  was  performed  after
10  sessions.  If  episodes  of  acute  exacerbations  occurred,  the
ﬁnal  assessment  was  performed  only  after  a  minimum  of
3  weeks  of  clinical  stability.
The  components  of  the  ﬁnal  evaluation  were  the  same
as  those  for  the  initial  assessment.  On  ﬁnal  evaluation
patients  also  responded  to  a  questionnaire  drawn  up  by  the
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poptimal  treatment  with  pharmacological  agents,  classic  pul-
monary  rehabilitation  and  oxygen,  many  patients  continue
to  be  symptomatic.3
It  is  well  known  that  respiration  is  an  essential  factor  for
singing  and  that  this  technique  involves  strong  fast  inspira-
tions,  followed  by  extended,  regulated  expirations,  which
require  accurate  control  of  breathing. 1,2,4--6
The  objective  of  this  study  was  to  investigate  the
effects  of  weekly  singing  classes  on  maximal  respiratory
pressures,  spirometric  measurements,  parameters  in  six-
minute  walk  test  (6MWT),  maximum  expiration  breathing
time  and  health-related  quality  of  life  (QoL)  in  patients  with
COPD.
Patients  with  COPD  who  were  attending  a  maintenance
pulmonary  rehabilitation  program  (90  min,  twice  a  week)
at  the  Physical  Medicine  and  Rehabilitation  Department  in
Pedro  Hispano  Hospital  were  invited  to  participate  in  the
study.  They  had  to  have  been  diagnosed  with  COPD  according
to  the  Global  Initiative  for  Chronic  Obstructive  Lung  Disease
(GOLD).  All  subjects  had  to  have  been  in  a  stable  clinical
condition  for  at  least  6  weeks  before  admission  to  the  study
and  to  have  signed  a  written  informed  consent  at  their  initial
visit.
Demographics,  height,  weight  and  clinical  history  were
recorded.  All  patients  initially  completed  plethysmography
(FVC,  FEV1,  FEV1/FVC,  TLC  and  RV);  maximal  inspiratory
and  expiratory  pressures  at  the  mouth  level  (MIP,  MEP);
assessment  of  QoL  employing  Saint  George’s  Respiratory
Questionnaire  (SGRQ),  COPD  Assessment  Test  (CAT)  and
EuroQoL  Test;  Hospital  Anxiety  and  Depression  Scale  (HADS);
London  Chest  Activity  of  Daily  Living  Scale  (LCADL)  and  Medi-
cal  Research  Council  Dyspnoea  Questionnaire  (mMRC)  for
dyspnea;  six  minutes  walk  test  (6MWT)  with  documentation
of  time  taken  to  recover  oxygen  saturation,  Modiﬁed  Borg
dyspnea  score  and  heart  rate  following  the  test.
Maximum  expiration  breathing  time  was  always  assessed
by  the  same  researcher.
The  patients  were  enrolled  in  weekly  classes  lasting
approximately  1  h,  for  10  weeks.  The  classes  were  coor-
dinated  by  a  singing  teacher  and  a  physiotherapist.  The
patients  participated  in  the  classes  as  a  group  and  the  activ-
ities  included  the  following:
(a)  Relaxation  exercises  of  neck  and  upper  and  lower  limb
muscles,  conducted  by  a  physiotherapist  (10--15  min);
b)  Vocalization  exercises,  led  by  the  singing  teacher,  as  a
preparation  for  singing  (15  min);
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researchers  (Fig.  1).
The  study  took  place  between  February  and  May  2013
10  sessions).  Eight  patients  were  selected  to  participate  in
he  study  but  two  of  them  were  subsequently  excluded.
Two  patients  were  dropped  from  the  study  because  they
id  not  attend  at  least  7  sessions.
The  results  are  listed  in  Tables  1  and  2.
Despite  the  small  number  of  patients  it  is  possible  to
bserve  that  the  FEV1 improved  from  1.15  L  (45%)  to  1.21  L
47%)  for  Patient  1,  remained  the  same  in  Patients  2  and  3
33  and  34%)  and  got  worse  in  Patient  4  (54--51%).
No  signiﬁcant  differences  were  observed  in  relation  to
esidual  volume  (RV)  and  total  lung  capacity  (TLC).  In
erms  of  maximum  expiratory  pressures  (MEP)  we  found
n  improvement  after  singing  lessons  in  only  three  of  the
atients.  Patient  3  was  the  only  patient  who  experienced COPD  exacerbation  during  study  time  and  was  the  only
atient  not  to  improve  MEP.
When  analyzing  the  results  for  the  6-minute  walk  test
6mWT)  we  observed  an  increase  in  the  distance  travelled
y  Patient  2  and  Patient  3  (60  m  for  Patient  2  and  99  m  for
atient  3)  and  a  decrease  for  Patient  1  and  4.  Only  Patient
 had  ﬁnal  oxygen  saturations  below  90%  when  the  test  was
erformed  after  the  singing  lessons  (before  the  program  only
hree  patients  had  oxygen  saturation  below  90%).  The  expi-
atory  time  decreased  in  all  patients  tested.
In  terms  of  quality  of  life  questionnaires  (Table  2)  we
ound  that  there  were  no  major  differences  between  the
re-  and  post-singing  session  results.
When  analyzing  the  answers  to  the  questionnaire  pre-
ared  by  the  researchers  we  found  that  all  patients  reported
mprovement  in  lung  function  control,  reduced  anxiety  and
ore  self-esteem  after  the  singing  lessons.  In addition,  all
atients  reported  a  feeling  of  well-being  and  recorded  the
xperience  as  very  pleasant.
The  aim  of  the  singing  lessons  was  to  improve  the  quality
f  life  in  patients  with  moderate  and  severe  COPD,  by  help-
ng  them  to  control  daily  symptoms  that  interfere  with  their
uality  of  life,  as  suggested  in  the  literature.
Functionally  MEP  tended  to  improve  MEP,  as  observed  in
ther  studies1 but  these  results  cannot  be  considered  valid
iven  the  low  number  of  patients  and  the  lack  of  a  control
roup.  The  expiratory  time  decreased  in  all  patients  tested.
Despite  their  not  having  ticked  major  differences  in  qual-
ty  of  life  questionnaires,  the  singing  program  was  perceived
y  patients  as  a  pleasant  experience,  which  is  similar  to  the
esults  found  in  the  literature.2,5,6
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Table  1  Respiratory  tests  before  and  after  the  program.
Patient  1  Patient  2  Patient  3  Patient  4
Gender/age  Male/68  Female/50  Male/68  Female/42
Supplementary oxygen?  No  Yes  (2  l/min)  No  Yes  (2  l/min)
Disease/stage COPD/GOLD  III  COPD/GOLD  IV  COPD/GOLD  IV  COPD/GOLD  III
Measurements Patient  1  Patient  2  Patient  3  Patient  4
BSP* ASP** BSP  ASP  BSP  ASP  BSP  ASP
FEV1  (L)  1.15  (45%)  1.21  (47%)  0.84  (33%)  0.85  (33%)  0.90  (34%)  0.87  (34%)  1.21  (54%)  1.21  (51%)
FEV1/FVC (%)  59  51  53  50  37  40  67  67
TLC (L)  6.14  (101%)  5.95  (98%)  4.72  (96%)  4.70  (95%)  9.38  (154%)  7.66  (126%)  3.90  (92%)  3.90  (92%)
FVC (L)  1.97  (59%)  2.38  (71%)  1.59  (53%)  1.71  (58%)  2.43  (72%)  2.20  (65%)  1.81  (66%)  1.81  (66%)
41  79  79
3  L  ( 5.07  (207%)  2.10  (143%)  2.10  (143%)
78  63  53
75  111  121
92  89  88
4  4  4
05  125  120
59  480  420
 13  12.5  8.5
ity; T diffusing capacity to alveolar volume; RV: residual
atory tes walk test; 6MWT (Final Borg Dyspnea): Modiﬁed
T (F tance/meters): distance traveled at the end of sixDLCO/Va (mmol/min/Kpa/L)  95  94  
RV (L)  3.95  L  (163%)  3.5
MIP 75  78  
MEP 86  88  
6MWT (O2 Sat)  92  93  
6MWT (ﬁnal  Borg  dyspnea)  5  4  
6MWT (ﬁnal  HR)  119  105  
6MWT (distance/meters)  480  440  
Expiratory time  (s)  14.9  12.6
FEV 1: forced expiratory volume in 1 s; FVC: forced vital capac
volume; MIP: maximal inspiratory pressure; MEP: maximal expir
Borg scale for dyspnea at the end of six minutes walk test; 6MW
minutes walk test.
* Before singing program.
** After singing program.18  16  35  
146%)  3.12  (180%)  2.99  (171%)  6.61  (272%)  
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Table  2  QoL  questionnaires  before  and  after  the  program.
Patient  1  P
Gender/age  Male/68  F
Supplementary  oxygen?  No  Y
Disease/stage  COPD/GOLD  III  C
Measurements  Patient  1  Pat
BSP* ASP** BSP  
SGRQ  19  17  22  
CAT 22  19  14  
EuroQoL 7  8  7  
mMRC 1  1  2  
HADS anxiety  7  6  7  
HADS depression  3  1  4  
LCADL 13  17  21  
SGRQ: St. George’s Respiratory Questionnaire; CAT: COPD Assess
Modiﬁed Medical Research Council Dyspnea Scale; HADS Anxiety: 
Depression: Hospital Anxiety and Depression Scale, pontuation for
* Before singing program.
** After singing program.
Questions 
1. Do you think that singing added some
2. Did singing lessons were a positive ex
3. Did singing lessons were a nice exper
4. Do you think that singing lessons adde
5. Do you think that singing lessons adde
6. Do you think that singing lessons adde
7. Do you think that singing lessons adde
8. What do you think was more importan
- the group spending time together 
- the warm up exercises 
- the singing exercises 
- the songs 
- the music 
- the professor 
9. Do you sing more at home now? 
10. Do you go out more now? 
11. Do you think singing lessons improved
12. Do you think singing lessons added so13. Do you think singing lessons had some nega
Figure  1  Questionnaire  draw227
t  2  Patient  3  Patient  4
e/50  Male/68  Female/42
No  Yes
GOLD  IV  COPD/GOLD  IV  COPD/GOLD  III
2  Patient  3  Patient  4
ASP  BSP  ASP  BSP  ASP
27  41  49  44  40
16  22  23  10  25
8  11  9  28  10
2  4  3  2  3
7  3  4  10  10
6  2  6  8  5
22  19  26  36  33
 Test; EuroQoL: questionnaire to measure health status; mMRC:
ital Anxiety and Depression Scale, punctuation for anxiety; HADS
ression; LCADL: London Chest Activity of Daily Living Scale.
it to pulmonary rehabilitation? If yes, explain.
ce? 
 
e benefit to your effort capacity? 
e benefit to your dyspnoea? 
e benefit to your breathing control? 
e benefit to your life satisfaction?   
in order): 
self confidence? 
nefit to your anxiety ? tive outcome? 
n  up  by  the  researchers.
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All  patients  said  that  the  project  should  be  continued  and
expanded.
The  present  data2,4 and  this  study  suggest  that  singing
does  produce  speciﬁc  beneﬁts  and  that  participation  in
singing  classes  should  be  encouraged  where  these  are  avail-
able.
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Pleural adenosine deaminase
in  the diagnostic workup of
tuberculous pleural effusion
Adenosina deaminase do liquido pleural na
abordagem diagnóstica do derrame pleural
tuberculoso
To  the  Editor,
Adenosine  deaminase  (ADA)  has  been  promoted  as  a  quick,
efﬁcient  and  cost-effective  method  in  the  diagnosis  of  tuber-
culous  effusions.1 However,  the  predictive  parameters  of
ADA,  in  the  diagnostic  workup  of  tuberculous  effusions,
depend  on  the  prevalence  of  the  disease  in  the  population2
and  no  such  analysis  has  been  published  in  Portugal,  a  coun-
try  of  intermediate  tuberculosis  (TB)  incidence  (25.9  per
100,000  in  2010).3
In  response  to  this  situation,  we  carried  out  a  cross-
sectional  analysis  over  a  4-year  period,  beginning  in  January
2006,  in  which  we  evaluated  pleural  ﬂuid  results  from  all
patients  admitted  to  our  department  with  a  pleural  effusion
of  unknown  etiology.  Only  the  results  obtained  from  the  ﬁrst
thoracocentesis  were  included  and  samples  from  empyema
were  excluded  from  our  analysis.  Pleural  ADA  was  measured
using  Giusti’s  colorimetric  method.  Mann--Whitney  test  was
performed  to  compare  medians  and  a  Receiver  Operating
Curve  (ROC)  was  used  to  determine  the  predictive  param-
eters  of  different  cutoffs.  Prism  6  from  Graphpad  Software
was  used  for  the  statistical  analysis.
A  total  of  107  pleural  samples  were  analyzed,  including
TB  (n  =  20),  malignant  (n  =  54),  parapneumonic  (n  =  20)  and
idiopathic  (n  =  13)  effusions.  Of  the  107  patients,  57.9%  were
males,  median  age  was  72.5  (interquartile  range:  59.7;  80.2)
and  all  the  patients  were  of  European  ethnicity.  TB  pleural
effusions  were  found  to  have  the  highest  median  ADA  value
(98.55  U/L),  which  were  signiﬁcantly  higher  than  malignant
effusions  (17.99  U/L)  (p  <  0.0001)  --  the  group  with  second
highest  median  ADA  value.  Using  the  ROC  curve  we  found
that  an  ADA  cutoff  of  40.5  U/L  had  the  best  performance  in
the  diagnosis  of  pleural  TB  (see  Table  1),  with  a  sensitivity
of  95%,  speciﬁcity  of  91.55%,  positive  predictive  value  (PPV)
of  73.08%  and  negative  predictive  value  (NPV)  of  98.77%.
Seven  nontuberculous  exudates  (8.0%)  reached  the  diagnos-
tic  cutoff.  Using  a  >50%  lymphocyte  count  criteria  in  the
diagnostic  workup,  only  4.5%  nontuberculous  exudates  were
misclassiﬁed  --  2  malignant  (plasmocytoma  and  lymphoma)
and  2  parapneumonic.  The  association  of  these  two  criteria
increased  speciﬁcity  (95.40%)  and  PPV  (82.61%).  Using  an
ADA  cutoff  level  of  74.6  U/L  and  the  >50%  lymphocyte  crite-
ria  further  increased  speciﬁcity  (98.85%)  and  PPV  (93.75%),
and  only  one  (1.1%)  nontuberculous  exudate  was  misclassi-
ﬁed.
The  diagnosis  of  tuberculous  pleural  effusion  is  a  common
diagnostic  challenge  due  to  low  mycobacterial  detection
rates  and  to  the  frequent  need  for  invasive,  sometimes
technically  difﬁcult,  operator  dependent  techniques  like  the
pleural  biopsy  or  thoracoscopy.4 In  this  context,  a  rational
interpretation  of  pleural  ﬂuid  characteristics,  particularly
ADA  level  and  differential  leukocyte  count,  is  essential  to
the  diagnostic  workup.  In  our  research,  an  ADA  level  <  40  U/L
can  virtually  exclude  pleural  TB  with  a  NPV  of  98.7%,  while
an  ADA  level  >  74.6  U/L  with  >50%lymphocyte  has  a  very
high  PPV  of  93.75  and  can  thus  be  used  to  safely  con-
ﬁrm  pleural  TB  with  a  very  small  error  rate  of  1.1%.  The
